The need for pharmacovigilance in sleep medicine
- PMID: 21731126
- PMCID: PMC3119823
- DOI: 10.5665/SLEEP.1096
The need for pharmacovigilance in sleep medicine
Comment on
-
Sedative medication use: prevalence, risk factors, and associations with body mass index using population-level data.Sleep. 2011 Jul 1;34(7):869-74. doi: 10.5665/SLEEP.1116. Sleep. 2011. PMID: 21731136 Free PMC article.
References
-
- London, UK: World Health Organization; 2002. The importance of pharmacovigilance: Safety monitoring of medicinal products.
-
- Wu JH, Howard DH, McGowan JE, Jr., et al. Patterns of health care resource utilization after macrolide treatment failure: results from a large, population-based cohort with acute sinusitis, acute bronchitis, and community-acquired pneumonia. Clin Ther. 2004;26:2153–62. - PubMed
-
- Mukherjee D, Nissen SE, Topol EJ. Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA. 2001;286:954–9. - PubMed
-
- Topol EJ. Failing the public health--rofecoxib, Merck, and the FDA. N Engl J Med. 2004;351:1707–9. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
